Dr. Reddy's Laboratories, Inc. recalls Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's
Dr. Reddy's recalls 300 mg Clopidogrel tablets with failed dissolution testing at 18 months. This could affect medication effectiveness. Consumers should contact the manufacturer for details.
Lower-risk recall
Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.
Contact the company & request your remedy
What happened, in plain English
Dr. Reddy's is recalling 300 mg Clopidogrel tablets that failed dissolution testing after 18 months. This could mean the medication doesn't work as intended, which is serious for people taking blood thinners. Read more at govinfonow.com/recall/39438-dr-reddy-s-clopidogrel-tablets-recall-failed-dissolution-testing.
Source Summary by GovInfoNow · govinfonow.com/recall/39438-dr-reddy-s-clopidogrel-tablets-recall-failed-dissolution-testing · Updated October 5, 2026 · FDA enforcement record: FDA #D-0283-2019
Cite this page
“Dr. Reddy's Clopidogrel Tablets Recall: Failed Dissolution Testing.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39438-dr-reddy-s-clopidogrel-tablets-recall-failed-dissolution-testing. Based on FDA recall #D-0283-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0283-2019%22&limit=1).
Why it’s dangerous
The tablets failed dissolution testing at 18 months, meaning they may not release the active ingredient properly. This could reduce the medication's effectiveness for blood thinning.
Who’s affected
People prescribed Clopidogrel tablets by a doctor who received this specific product. Those with heart conditions or blood clot risks are most at risk.
How to tell if you have this one
Check for the product name 'Clopidogrel Tablets, USP, 300 mg', 30-count blister pack, and lot number T600530 with expiration 11/18.
- Brand
Dr. Reddy's- Category
Drug
What to do — step by step
Contact Manufacturer
Reach out to Dr. Reddy's Laboratories for specific instructions on handling the recalled product.
Questions people ask
Is this product dangerous?
The recall is due to failed dissolution testing, which could affect medication effectiveness. It is not immediately dangerous but requires medical attention.
How do I know if I have the recalled product?
Check for the product name 'Clopidogrel Tablets, USP, 300 mg', 30-count blister pack, and lot number T600530 with expiration 11/18.
What should I do if I have this product?
Contact Dr. Reddy's Laboratories for specific instructions on handling the recalled product.
Contact Dr. Reddy's
We’ve drafted a message you can send Dr. Reddy's to request your refund or repair — edit it as you like.
Subject: Recall D-0283-2019 — Dr. Reddy's Dr. Reddy's Hello, I own a Dr. Reddy's that is covered by recall D-0283-2019 from Dr. Reddy's. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0283-2019 (November 7, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0283-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.